Infinity Pharmaceuticals, Inc.
INFIDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001113148
Infinity Pharmaceuticals, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 45
- Q2 2023, −8 vs. previous quarter
- 13F value
- $4.23M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- $2.59M
- +39.6% year over year
- Net income, FY2022
- -$44.4M
- No comparable prior period
- Free cash flow, FY2022
- -$42.4M
- No comparable prior period
- Revenue, Q2 FY2023
- $583.0K
- −15.0% year over year
Revenue flow, FY2022
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2022: $44.4M (1711.1% of revenue).
Superinvestors holding INFI, Q2 2023
Go to the superinvestors tabNo superinvestor reported holding INFI at the end of Q2 2023.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Infinity Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing)6:20 PM ET | Sep 12 | Same day | Perkins Adelene QDirector | SSale | −410.2K | $0.07 | −$28.7K | −25.9%1.18M after | 10b5-1 |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Peluso StephaneChief Scientific Officer | SSale | +15.0K | $0.66 | +$9.90K | +68.0%37.1K after |
Top 10 13F holders, Q2 2023
See all 45 holdersThe largest institutional positions in Infinity Pharmaceuticals, Inc. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 6,353,645 | $1.34M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,981,857 | $838.2K | 0.00% | −13,017−0.3% | Reduced |
| Sphera Funds Management Ltd. | 1,476,000 | $310.7K | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 1,461,881 | $307.7K | 0.00% | +3520.0% | Added |
| Carlson Capital L P | 1,300,000 | $273.6K | 0.02% | +300,000+30.0% | Added |
| Mariner, LLC | 1,195,000 | $252.0K | 0.00% | +1,195,000 | New |
| Geode Capital Management, LLC | 807,517 | $170.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 696,506 | $146.6K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 358,200 | $75.0K | 0.00% | +123,200+52.4% | Added |
| State Street Corp | 334,360 | $70.4K | 0.00% | −7,700−2.3% | Reduced |